snoRNAs Offer Novel Insight and Promising Perspectives for Lung Cancer Understanding and Management.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
26 02 2020
Historique:
received: 31 01 2020
revised: 21 02 2020
accepted: 24 02 2020
entrez: 1 3 2020
pubmed: 1 3 2020
medline: 20 2 2021
Statut: epublish

Résumé

Small nucleolar RNAs (snoRNAs) are non-coding RNAs localized in the nucleolus, where they participate in the cleavage and chemical modification of ribosomal RNAs. Their biogenesis and molecular functions have been extensively studied since their identification in the 1960s. However, their role in cancer has only recently started to emerge. In lung cancer, efforts to profile snoRNA expression have enabled the definition of snoRNA-related signatures, not only in tissues but also in biological fluids, exposing these small RNAs as potential non-invasive biomarkers. Moreover, snoRNAs appear to be essential actors of lung cancer onset and dissemination. They affect diverse cellular functions, from regulation of the cell proliferation/death balance to promotion of cancer cell plasticity. snoRNAs display both oncogenic and tumor suppressive activities that are pivotal in lung cancer tumorigenesis and progression. Altogether, we review how further insight into snoRNAs may improve our understanding of basic lung cancer biology and the development of innovative diagnostic tools and therapies.

Identifiants

pubmed: 32111002
pii: cells9030541
doi: 10.3390/cells9030541
pmc: PMC7140444
pii:
doi:

Substances chimiques

RNA, Small Nucleolar 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Nat Genet. 2016 Jan;48(1):53-8
pubmed: 26595770
Lab Invest. 2011 Apr;91(4):579-87
pubmed: 21116241
Oncogene. 2014 Mar 13;33(11):1348-58
pubmed: 23542174
Cell Death Differ. 2008 Mar;15(3):504-14
pubmed: 18049477
Virchows Arch. 2017 Aug;471(2):221-233
pubmed: 28730537
Trends Mol Med. 2013 Nov;19(11):643-54
pubmed: 23953479
Tunis Med. 2017 Novembre;95(11):965-971
pubmed: 29877554
Ann Thorac Surg. 2017 Jun;103(6):1795-1801
pubmed: 28274517
Front Genet. 2019 May 16;10:478
pubmed: 31156715
Cancer Discov. 2018 Dec;8(12):1614-1631
pubmed: 30266814
Mol Cancer Res. 2009 Mar;7(3):330-8
pubmed: 19276181
Oncotarget. 2017 Jan 17;8(3):4530-4542
pubmed: 27965463
J Exp Clin Cancer Res. 2015 May 15;34:49
pubmed: 25975345
Cell. 1996 Sep 6;86(5):823-34
pubmed: 8797828
Cell. 1990 Mar 23;60(6):897-908
pubmed: 2156625
Trends Genet. 2019 Feb;35(2):104-117
pubmed: 30563726
Clin Transl Med. 2015 Apr 21;4:16
pubmed: 25977750
Cell. 2010 Apr 2;141(1):69-80
pubmed: 20371346
Cancers (Basel). 2019 Aug 14;11(8):
pubmed: 31416190
J Cancer. 2019 May 21;10(10):2261-2275
pubmed: 31258730
Cells. 2019 Jan 15;8(1):
pubmed: 30650663
Lung Cancer. 2010 Feb;67(2):170-6
pubmed: 19446359
Biochim Biophys Acta. 2012 Aug;1826(1):121-8
pubmed: 22498252
Tumour Biol. 2016 Feb;37(2):1437-44
pubmed: 26634743
Proc Natl Acad Sci U S A. 2016 Mar 22;113(12):E1625-34
pubmed: 26957605
Curr Opin Cell Biol. 1997 Jun;9(3):337-42
pubmed: 9159079
Nat Genet. 2008 Jun;40(6):719-21
pubmed: 18500341
Int J Cancer. 2015 Mar 15;136(6):E623-9
pubmed: 25159866
Nucleic Acids Res. 2015 Dec 2;43(21):10474-91
pubmed: 26405199
Int J Mol Sci. 2019 May 02;20(9):
pubmed: 31052553
PLoS One. 2017 Aug 17;12(8):e0183410
pubmed: 28817650
Bioessays. 2017 Jun;39(6):
pubmed: 28505386
Oncogene. 2002 Oct 7;21(45):6877-83
pubmed: 12362270
Oncotarget. 2016 Feb 2;7(5):5131-42
pubmed: 26246471
RNA Biol. 2017 Jun 3;14(6):680-692
pubmed: 27715451
Annu Rev Biochem. 1995;64:897-934
pubmed: 7574504
J Pathol. 2018 Apr;244(5):565-577
pubmed: 29344953
RNA Biol. 2018;15(6):829-831
pubmed: 29671387
PLoS One. 2010 Apr 22;5(4):e10312
pubmed: 20421987
Nat Struct Mol Biol. 2015 Jan;22(1):11-9
pubmed: 25565028
Cancer Res. 2014 Jul 1;74(13):3579-90
pubmed: 24812274
Curr Opin Genet Dev. 2005 Feb;15(1):87-96
pubmed: 15661538
Mol Cell. 2008 Nov 21;32(4):519-28
pubmed: 19026782
Genomics. 2009 Aug;94(2):83-8
pubmed: 19446021
Methods Mol Biol. 2018;1740:1-15
pubmed: 29388131
Mol Cancer. 2014 May 06;13:104
pubmed: 24886050
NPJ Precis Oncol. 2017;1:
pubmed: 29152593
J Biophys Biochem Cytol. 1959 Aug;6(1):57-60
pubmed: 13673047
Clin Cancer Res. 2019 Aug 1;25(15):4592-4602
pubmed: 30824587
Signal Transduct Target Ther. 2016 Jan 28;1:15004
pubmed: 29263891
Oncotarget. 2016 Sep 13;7(37):59519-59534
pubmed: 27517747
Cancer Cell. 2017 Feb 13;31(2):256-269
pubmed: 28110998
Cancer Cell. 2013 Sep 9;24(3):318-30
pubmed: 24029231
Biochimie. 2011 Nov;93(11):1987-92
pubmed: 21664409
PLoS Pathog. 2011 Jul;7(7):e1002121
pubmed: 21829345
Gut. 2017 Jan;66(1):107-117
pubmed: 26475630
Perspect Clin Res. 2016 Apr-Jun;7(2):68-74
pubmed: 27141472
Mol Cell Oncol. 2015 Mar 24;2(3):e983755
pubmed: 27305893
Front Oncol. 2019 Sep 06;9:788
pubmed: 31552164
Mol Cancer. 2016 May 12;15(1):36
pubmed: 27176474
Oncogene. 2012 May 31;31(22):2794-804
pubmed: 21986946
Proc Natl Acad Sci U S A. 2017 Dec 5;114(49):12934-12939
pubmed: 29158377
Nucleic Acids Res. 2016 Jun 20;44(11):5068-82
pubmed: 27174936
Nat Med. 2016 Mar;22(3):262-9
pubmed: 26828195
Biomed Res Int. 2017;2017:7404912
pubmed: 28127559
Cancers (Basel). 2019 Apr 29;11(5):
pubmed: 31035693
Biochem Pharmacol. 2019 Apr;162:169-176
pubmed: 30414937
J Pathol. 2014 Jan;232(2):121-33
pubmed: 24114583
Nucleic Acids Res. 2017 Sep 6;45(15):8647-8660
pubmed: 28911119
Tumour Biol. 2015 Jan;36(1):41-53
pubmed: 25420907
Trends Cancer. 2016 Jul;2(7):350-364
pubmed: 27819059
Nat Cell Biol. 2017 Jul;19(7):844-855
pubmed: 28650479
Biomolecules. 2018 Oct 03;8(4):
pubmed: 30282949
Front Genet. 2015 Jan 26;6:2
pubmed: 25674102
Open Biol. 2017 Sep;7(9):
pubmed: 28878044
Mol Cancer. 2010 Jul 27;9:198
pubmed: 20663213
Chest. 2013 May;143(5 Suppl):e142S-e165S
pubmed: 23649436
Lancet. 2019 May 4;393(10183):1819-1830
pubmed: 30955977
Stem Cell Investig. 2014 Apr 15;1:9
pubmed: 27358855
J Thorac Oncol. 2015 Sep;10(9):1243-1260
pubmed: 26291008
Int J Biochem Cell Biol. 2018 Sep;102:138-150
pubmed: 30053504
Cell Rep. 2017 Nov 14;21(7):1968-1981
pubmed: 29141226

Auteurs

Nour-El-Houda Mourksi (NE)

Univ Lyon, University Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69373 Lyon Cedex 08, France.

Chloé Morin (C)

Univ Lyon, University Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69373 Lyon Cedex 08, France.

Tanguy Fenouil (T)

Univ Lyon, University Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69373 Lyon Cedex 08, France.
Hospices Civils de Lyon Institute of Pathology EST, Site Est-Groupement Hospitalier Est, 69677 Bron, France.

Jean-Jacques Diaz (JJ)

Univ Lyon, University Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69373 Lyon Cedex 08, France.

Virginie Marcel (V)

Univ Lyon, University Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69373 Lyon Cedex 08, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH